DiaMedica Therapeutics Inc.
DMAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,444 | -$19,381 | -$13,676 | -$13,592 |
| Dep. & Amort. | $39 | $30 | $25 | $24 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,085 | $1,683 | $1,502 | $1,558 |
| Change in WC | $1,512 | $93 | $585 | -$461 |
| Other Non-Cash | -$1,268 | -$1,153 | $53 | $219 |
| Operating Cash Flow | -$22,076 | -$18,728 | -$11,511 | -$12,252 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$25 | -$24 | -$81 | -$22 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$50,411 | -$69,410 | -$45,684 | -$69,813 |
| Inv. Sales/Matur. | $59,000 | $51,135 | $57,303 | $49,296 |
| Other Inv. Act. | $0 | $0 | $0 | $2 |
| Investing Cash Flow | $8,564 | -$18,299 | $11,538 | -$20,537 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9 | -$6 | -$6 | -$6 |
| Stock Issued | $11,747 | $36,848 | $0 | $29,849 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $256 | $0 | $0 | $244 |
| Financing Cash Flow | $11,994 | $36,842 | -$6 | $30,087 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,518 | -$185 | $21 | -$2,702 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,543 | $4,728 | $4,707 | $7,409 |
| End Cash | $3,025 | $4,543 | $4,728 | $4,707 |
| Free Cash Flow | -$22,101 | -$18,752 | -$11,592 | -$12,274 |